Arkolith/Insider Trading/ANGN/Form 4

Venkatesan Jay

See Remarks, DirectorAngion Biomedica Corp. (ANGN) · full profile →Form 4 · filed Dec 29, 2021
Net Buying
Open-Market Buys
$730K
Open-Market Sells
$0
Net Open-Market Flow
$730K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 28, 2021Buy(P)210K$2.66$559K1.6M
Dec 27, 2021Buy(P)67K$2.55$171K1.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001601485-21-000095) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML